1217 Fin QT
BioCentury & Getty Images

Deals

Dec. 17 Quick Takes: Ultragenyx gains rights to Mereo’s setrusumab; plus Verily’s $700M raise, dMed’s listing plans, Virios’ IPO   

Dec 18, 2020 | 1:36 AM GMT

Ultragenyx gains ex-Europe rights

Read the full 321 word article

How to gain access

Continue reading with a
two-week free trial.